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Abstract
Background: Pyomyositis is an acute bacterial infection of skeletal muscle that results in localized abscess formation.
This infection was thought to be endemic to tropical countries, and is also known as “tropical pyomyositis”.
However, pyomyositis is increasingly recognized in temperate climates and is frequently associated with an
immunosuppressive condition, such as human immunodeficiency virus, malignancy, and diabetes mellitus. It is also
found in healthy and athletic people after strenuous or vigorous exercise or following localized and possibly unnoticed
trauma. It can be primary or secondary to neighboring or remote infection. Primary pyomyositis is a rare condition that
can affect children and adolescents. Diagnosis can be delayed because the affected muscle is deeply situated and local
signs are not apparent. This delay in diagnosis can result in increased morbidity and a significant mortality rate. The
pediatric population, which comprises 35% of the reported pyomyositis cases, is an especially difficult subset of
patients to diagnose.
Case presentation: In our series, we describe the cases of four previously healthy Caucasian children who were
admitted to our Pediatric Department with different clinical presentations. Pyomyositis in our patients was related to
factors affecting the muscle itself, including strenuous exercise and direct muscle trauma. Therapy was started with a
cephalosporin antibiotic and teicoplanin was subsequently added. The minimum length of therapy was 3 weeks.
Conclusions: The diagnosis of pyomyositis in our patients, none of whom were immune-compromised, is
confirmation that this disease is not an exclusive pathology of tropical countries and demonstrates that there is an
increasing prevalence of pyomyositis in temperate climates.
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Background
Pyomyositis is a bacterial infection that results in an
intramuscular abscess of the large skeletal muscle
groups. The first case was documented by Scriba in
Japan in 1885 [1] but the first report in North America
did not appear until 1971 [2]. This infection is endemic
to tropical countries, accounting for 2.2–4% of surgical
admissions [1]. It is much less common in temperate
climates, such as North America, where only 98 cases
were reported between 1972 and 1992 [3]. In tropical
countries, peak incidence is at 2–5 years of age; in North
America, the mean age is 8.4 years with a range of 1–16
years [1].
Primary pyomyositis is common in many parts of
Africa and in the South Pacific, and has earned the name
“tropical pyomyositis.” It occurs more frequently in
immune-compromised patients, though it can be related
to factors affecting the muscle itself (strenuous exer-
cise, direct muscle trauma, viral or parasitic myositis)
[4]. Secondary pyomyositis is usually a consequence
of direct extension from an infectious process, most
notably Crohn’s disease, infectious colitis, appendicitis,
and neoplasia. The pathogenesis of the disease is not
clear, but trauma, malnutrition, viral and parasitic
infections, bacteremia, immunodeficiency or chronic
illness, and other factors may have predisposing roles
[1]. Intensive exercise and local trauma have been
suggested as risk factors, but only a third of patients
had evidence of these risk factors [5]. Because of its rarity
and often vague clinical presentation, it is unlikely to be
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considered during an initial differential diagnosis.
Moreover, the diagnosis can be delayed because the
affected muscle is deeply situated and local signs are
not apparent. This delay in diagnosis can result in in-
creased morbidity and a significant mortality rate [6].
The pediatric population, which comprises approxi-
mately 35% of reported cases, is an especially difficult
subset of patients to diagnose [7].
Pyomyositis predominantly affects the muscles of the
lower limbs, although it can also involve muscles of
the upper limb, trunk, and spine (Fig. 1). In the lower
limb, the most commonly affected muscles are the
quadriceps and iliopsoas followed by the gluteal muscles.
Pyomyositis originating in the obturator internus or/and
external muscles is exceptionally rare; it occurs most
commonly in children and young adults and exhibits a 2:1
prevalence in male patients [6].
If the disease is recognized early, antibiotic therapy
alone is usually sufficient. Initial therapy should
include a broad-spectrum agent with adequate
Staphylococcus aureus coverage, and therapy should
subsequently be modified depending on results of
blood culture and sensitivity tests. Coverage of Gram-
negative organisms should be empirically included in
the treatment of immunocompromised patients. The
therapy is initially administered intravenously and




A 6–5/12-year-old Caucasian boy was admitted to our
Pediatric Department with fever, pharyngitis, lateral
cervical and inguinal lymphadenomegaly, limp, and pain
in his proximal right thigh (medial side) during walking
and on palpation. Prior to admission, he had a 12-day
history of intermittent-remittent fever up to 39.3 °C,
treated with paracetamol (acetaminophen). At admis-
sion, his C-reactive protein (CRP) concentration was
7.17 mg/dl (normal value <0.5 mg/dl) and he had
leukocytosis (white blood cells (WBC) 19.36 × 103/μl)
and neutrophilia (15.77 × 103/μl; 81.4%). For this reason,
intravenous antibiotic treatment with ceftriaxone was
started. Right lower limb venous ultrasonography
excluded phlebitis or phlebothrombosis. Nevertheless,
his CRP concentration increased to 15.90 mg/dl, his
erythrocyte sedimentation rate (ESR) was 51 mm/h
(normal value <20 mm/h), and there was a further
increase in his leukocytosis (WBC 22.30 × 103/μl) and
neutrophilia (17.94 × 103/μl; 80.5%); his antistreptolysin
O (ASO) titer was 451 UI/ml (normal value <200 UI).
Ultrasonography of his thigh muscles and hip was per-
formed, showing a minimal fluid intrafascial thickening
of his proximal adductor muscle. Double antibiotic
therapy with ceftriaxone and teicoplanin was therefore
started. Magnetic resonance imaging (MRI) with con-
trast confirmed the proximal thickening of his right
Fig. 1 Anatomic distribution of pyomyositis modified from Bickels et al. [8]
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proximal longus and magnus adductor muscles and ipsi-
lateral proximal gracilis muscle, attributable to an in-
flammatory process, without any involvement of his
joints. Results from subsequent laboratory tests showed
a reduction in inflammatory markers (CRP 0.77 mg/dl,
ESR 14 mm/h), an improvement in leukocyte (13.99 ×
103/μl) and neutrophil (9.07 × 103/μl; 64.8%) concentra-
tions, and normalization of his ASO titer. On the eighth
day of treatment, the ceftriaxone therapy was inter-
rupted and teicoplanin was administered for a further 7
days. At discharge, after normalization of his laboratory
test results, oral therapy with amoxicillin plus clavulanic
acid was started for an additional 7 days. A control MRI
scan highlighted a nearly complete resolution of the pyo-
myositis in both muscles with a regression of fever, limp,
and pain. The length of therapy was 3 weeks.
Case 2
A 15-year-old Caucasian boy presented to our Pediatric
Department with pain in his right buttock that began a
week after a 3-km run and a bowling match, with radi-
ation of the pain in his lumbar region that was aggra-
vated by movement and an inability to walk unaided.
There were no associated abdominal or urinary symp-
toms. Before admission, he had fever up to 39 °C. A
physical examination showed fever (38.2 °C), right low
back pain, a positive result on a leg raise test, and func-
tional limitation in his right lower limb. He had some
discomfort in his right groin on deep palpation to his
right buttock lateral to the ischial tuberosity. Our patient
was unable to ambulate independently but his muscle
tone, strength, and reflexes were preserved. No sensory
deficit of his right lower limb was noted. There ere no
palable inguinal lymph nodes.
Initial laboratory studies revealed leukocytosis and
neutrophilia (15 × 103/μl; 90%), a CRP concentration of
15.80 mg/dl (normal value <0.5 mg/dl), and an ESR of
54 mm/h (normal value <20 mm/h). Involvement of the
lower limb nerve was suspected. Routine radiography of
both his hips and pelvis demonstrated no abnormalities.
He was started on diclofenac for the pain and oral anti-
biotic treatment with amoxicillin plus clavulanic acid.
An MRI of his lumbosacral spine and pelvis was per-
formed; the examination showed an increased silhouette
on his right side associated with areas of altered signal
in the iliopsoas muscle, obturator, and gluteus medius
and maximus. Some fluid collection (the largest of which
measured up to 6 cm on the craniocaudal diameter),
edema between the paraspinal muscles at L4–L5, and
bilateral edema of the plan of dermal-subcutaneous
thigh root were also reported in the posterolateral view.
The antibiotic therapy was therefore replaced with
ceftazidime and teicoplanin. A blood sample, taken on
the 14th day of antibiotic therapy, showed a decrease in
inflammatory markers (CRP 2.41 mg/dl, ESR 14 mm/h)
and in neutrophilic leukocytosis (WBC 12.6 × 103/μl,
neutrophils 8.5 × 103/μl). A control MRI scan
highlighted a slight reduction in the fluid collections in
his iliopsoas and obturator muscles, with the fluid
collection in his gluteal muscles converted into an
abscess, characterized by a mildly hyperintense labrum
on T1-weighted MRI. At discharge, after normalization
of his laboratory test results, oral therapy with amoxicil-
lin plus clavulanic acid was started for an additional 4
weeks. The total length of therapy was 6 weeks.
Case 3
An 8-year-old Caucasian boy presented to our Pediatric
Department with a 1-week history of fever, pain, and
impairment in walking owing to left leg pain. Before ad-
mission, he was treated with cephalosporin (ceftriaxone),
acetaminophen, and ketoprofen without benefit. No
association with trauma or previous infection was
reported, but a knee injury was observed. A physical
examination showed antalgic positioning of his left hip,
warmth and pain on palpation of the proximal posterior
region of his left leg, and stiffness and pain during leg
movements. Neurological, respiratory, and cardiovascular
examinations were normal. Laboratory tests documented
an increased CRP concentration (6.25 mg/dl, normal
value <0.5 mg/dl), ESR (72 mm/h, normal value <20
mm/h), leukocyte count (WBC 15.85 × 103/μl), and
creatine phosphokinase (CPK) (237 U/L). He had
positive titer tests for ASO (648 UI/ml) and anti-
staphylococcal antibodies. Owing to the suspicion of a
S. aureus infection, a double therapy with cephalosporin
and glycopeptide antibiotics (ceftriaxone plus teicoplanin)
was undertaken for 8 days. A hip X-ray documented react-
ive changes in the lesser trochanter of his femur and an
ultrasound scan showed a hematoma at the proximal third
of the posterior side of his thigh. MRI showed inflamma-
tion of his obturator and adductor magnus muscles. Our
patient was discharged on oral antibiotic therapy for 10
days. The follow-up visits documented a gradual reso-
lution of symptoms, normal laboratory test results, and re-
duced muscle inflammation in an MRI scan. No drainage
was necessary. The length of therapy was 3 weeks. A few
months later our patient was symptom free.
Case 4
A 10–6/12-year Caucasian girl presented to our
Pediatric Department with pain localized to her right
thigh for 8 days’ duration, with significant movement
restriction, an inability to bear weight, and fever (up to
39.7 °C). Our patient had been treated at home with
anti-inflammatory therapy (ibuprofen). Normal results
were seen on ultrasonography of her right hip and on
right pelvic and hip radiography. On examination, our
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patient had an attitude of flexion and adduction in her
right hip, evident restriction of her right lower limb
movements, and painful passive mobilization. The pain
worsened when the proximal adductor region was palpi-
tated. There was also swelling over the medial side of
the root of her thigh. Laboratory studies showed
elevated CRP levels (14.4 mg/dl, normal value <0.5 mg/
dl), a slight increase in lactic dehydrogenase values (712
U/l), and neutrophilia (10.7 × 103/μL; N: 7:57 × 103/μL).
Her ESR was not measured in the emergency room.
Septic arthritis was suspected and intravenous antibiotic
therapy with ceftazidime and anti-inflammatory therapy
with ibuprofen were started. MRI of her pelvis and lum-
bosacral spine demonstrated intra-articular effusion of
her right hip joint with short TI inversion recovery
(STIR) hyperintensity in her ipsilateral adductor muscles.
Follow up blood tests documented a progressive reduc-
tion of CRP (1.29mg/dL); ESR: 47 mm/h) and
normalization of her WBC count (7.12 × 103/μL). Results
from a Widal-Wright test and blood culture were nega-
tive. Results from a urine analysis were normal. Owing
to a positive anti-staphylococcal antibody titer, teicopla-
nin was added to her ceftazidime therapy. During her
hospitalization, our patient’s clinical condition progres-
sively improved: her fever disappeared in 10 days with
remission of the painful limitation to active and passive
motions of her right hip after 12 days, and subsequent
recovery of ambulation. Our patient was discharged with
an oral course of amoxicillin-clavulanate treatment, thus
completing a 3-week cycle of antibiotic therapy. A sec-
ond MRI was performed after therapy completion, which
showed nearly complete resolution of the inflammatory
changes. At a 1-month follow-up, our patient was symp-
tom free without sequelae.
Discussion
The clinical presentation of pyomyositis in our series
was varied. Results from a physical examination are
usually not clear and the diagnosis is often delayed. A
mean delay of 10 days from the onset of the symptoms
to correct diagnosis has been reported in the literature
[8]. Some authors have outlined three stages of pyo-
myositis as a gradual progression from diffuse inflam-
mation to focal abscess formation in a septic state
(Table 1) [1–3, 5, 6, 9–12]. In our series, all patients
were at stage 2.
Laboratory investigations are not specific and are rarely
helpful in the diagnosis of pyomyositis [8]. In our series, we
reported the same laboratory findings as found in previous
studies, such as moderate leukocytosis with a left shift,
elevation of ESR and CRP, and normal muscle enzyme
levels [1], although an increase in CPK was also docu-
mented in case 3. Three cases involved an elevated ASO
titer and two had positive staphylococcal antibody titers.
Imaging is the best modality to define the features and the
extent of muscle infection.
Various noninvasive diagnostic modalities such as
ultrasound, computed tomography (CT), and MRI have
been used to evaluate patients with suspected musculo-
skeletal infection [13]. Plain radiography is appropriate
for the initial screening [8]. Only a minority of patients
have findings suggestive of muscle inflammation. X-rays
was performed only in case number 3 and it failed to
document the specific reactive change in the adjacent
bone. A CT scan provides better delineation of muscle
than X-rays and can identify a muscle abscess, but it
may fail to demonstrate inflammatory changes in earlier
stages [8]. In our series, no CT scans were performed
when ultrasonography was used. The typical findings on
radiography are a bulky muscle with abnormal echotex-
ture and a hypoechoic focal lesion, occasionally with in-
ternal debris and air bubbles [8, 14]. In our cases,
ultrasonography allowed visualization of significant
muscle inflammation. MRI is the gold standard, showing
the extent of involvement and the site of fluid collection.
It offers the additional advantage of being able to study
the adjacent structures, such as joints, bone, and soft tis-
sue [15], and is therefore helpful to differentiate other
pathological processes from pyomyositis [12], such as in-
fectious arthritis of the hip, osteomyelitis, hematoma, or
Table 1 Clinical stages of pyomyositis [1–3, 5, 6, 8–11]
Stage 1 Invasive About 2% of patients present in this stage. This stage lasts from 10 to 21 days.
Insidious onset of dull, cramping pain, a low-grade fever, muscle ache, general malaise, and
anorexia. There is localized edema, sometimes described as indurated or woody, with little or
no tenderness. There is no abscess, and examination of aspiration specimens is unrevealing.
Stage 2 Purulent or suppurative About 90% of patients present in this stage. In one study, the mean duration of symptoms
before hospitalization was 24 days, whereas in other studies it was respectively 12 days and
6.2 days. Fever and chills. This phase is characterized by abscess formation. Pathologic
findings on biopsy show edematous muscle fibers, lymphocytic infiltration, and suppuration
as the muscle belly is replaced by pus.
The involved muscle is usually tender and the overlying skin may be normal or mild eruptive.
Stage 3 Late stage High fever, severe pain, local signs of infection and systemic manifestations of sepsis may be
present. The final stage is characterized by septicemia, metastatic abscesses, and multi-organ
dysfunction, and is associated with high mortality.
There is exquisite tenderness of the involved area.
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soft-tissue tumor [8]. All four of our patients underwent
MRI, which was very helpful in defining the appropriate
therapy. In three cases, MRI was also repeated to evaluate
the resolution of inflammation. Technetium or gallium
scintigraphy is rarely used in the diagnosis of pyomyositis,
but it may assist the diagnostic process when the clinical
presentation is equivocal [8].
Clinical manifestations of pyomyositis are varied so it
is very important to make an early and correct diagnosis
and to exclude other pathologies (Table 2).
The choice of treatment is usually related to the stage
of disease at presentation. Prompt, accurate diagnosis
followed by early initiation of intravenous antibiotics can
prevent abscess formation and avoid surgical drainage
[10]. In the early invasive stage, in the absence of a
drainable collection of purulent fluid on MRI, diffuse
inflammation can be treated empirically with antibiotics
alone [16]. On the basis of the most likely culpable
bacteria, cloxacillin is a common choice. A combination
of cloxacillin and aminoglycoside achieves a synergic
effect for septic or immunocompromised patients [8].
Most patients with primary pyomyositis can be treated
successfully with intravenous administration of a single
antibiotic. In our series, the therapy was started empirically
with a double antibiotic therapy with cephalosporin and
glycopeptide antibiotics (ceftriaxone, cefixime, or ceftazi-
dime plus teicoplanin) for at least 2 weeks to cover S.
aureus and Gram-negative infection. Antibiotic therapy
was discontinued when physical signs and symptoms dis-
appeared and blood test results and CRP concentration
returned to normal values. The duration of therapy has not
been established and can vary from 2 to 6 weeks, depend-
ing on clinical severity and the patient’s response. Patients
who have an underlying disease that compromises their
immunity may require a longer period of intravenous and
oral antibiotic treatment [8].
Abscess formation, however, requires appropriate
drainage before starting antibiotics. Because most
patients are not seen until an abscess has already formed
(stages 2 and 3), drainage followed by intravenous
administration of at least two broad-spectrum antibiotics
remains the treatment of choice [8]. When the patho-
genic agent is isolated, antibiotic therapy should be ad-
justed according to the result of culture and sensitivity
tests [10]. In many series, despite abscess formation in
some patients, neither surgical nor percutaneous drain-
age are needed. Traditionally, abscesses were drained by
operative means, which entailed a large skin incision and
a wide exposure of the affected muscle. Similarly, iliop-
soas pyomyositis necessitated laparotomy and extensive
retroperitoneal exposure. Following operative drainage,
packing and daily dressing changes were necessary to
prevent the abscess cavity from closing prematurely [17].
However, now drainage can be accomplished percutan-
eously under ultrasound or CT guidance, and operative
intervention is used only when complete drainage can-
not be achieved percutaneously. Streptococcal pyomyosi-
tis is associated with extensive muscle necrosis that
requires not only abscess drainage, but also radical exci-
sion of all necrotic tissues. When there has been a delay
in diagnosis, a more extensive debridement and, rarely,
amputation may be needed [8]. A diagnostic delay could
lead to sepsis and death [15], so it is very important to
choose the correct diagnostic approach.
Conclusions
Pyomyositis in our series was related to factors affecting
the muscle itself, including strenuous exercise and direct
muscle trauma. The gold standard for diagnosing
pyomyositis is MRI. Ultrasonography is useful for moni-
toring muscle inflammation. In our series, therapy was
started with a cephalosporin antibiotic and teicoplanin
was subsequently added to cover S. aureus infection.
The minimum length of treatment was 3 weeks. Our pa-
tients, none of whom were immune-compromised, lived
in a temperate climate, confirming that pyomyositis is
not an exclusive pathology of tropical countries.
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Table 2 Symptoms and differential diagnosis [1, 10, 15, 18–22]
Specific site of tenderness and
swelling
Osteomyelitis, septic arthritis [1]





Localized muscular mass, painless
slow-growing masses, painful mass
increasing in size
Sarcoma [19, 20]
Pain in right lower quadrant, back,
flank, or hip; fever
Acute appendicitis or acute disease
of hip or femoral nerve [21]
Myalgia, weakness, tea-colored
urine
Rhabdomyolysis [14, 22, 23]
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